These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15264228)

  • 1. Cytotoxic mechanisms by M239V presenilin 2, a little-analyzed Alzheimer's disease-causative mutant.
    Abe Y; Hashimoto Y; Tomita Y; Terashita K; Aiso S; Tajima H; Niikura T; Matsuoka M; Nishimoto I
    J Neurosci Res; 2004 Aug; 77(4):583-95. PubMed ID: 15264228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons.
    Niikura T; Yamada M; Chiba T; Aiso S; Matsuoka M; Nishimoto I
    J Neurosci Res; 2004 Jul; 77(1):54-62. PubMed ID: 15197738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2.
    Hashimoto Y; Niikura T; Ito Y; Kita Y; Terashita K; Nishimoto I
    J Pharmacol Exp Ther; 2002 Mar; 300(3):736-45. PubMed ID: 11861776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino- and carboxyl-terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: Study of 27 different presenilin 1 mutants.
    Hashimoto Y; Tsukamoto E; Niikura T; Yamagishi Y; Ishizaka M; Aiso S; Takashima A; Nishimoto I
    J Neurosci Res; 2004 Feb; 75(3):417-28. PubMed ID: 14743455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
    Walker ES; Martinez M; Brunkan AL; Goate A
    J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin target.
    Hashimoto Y; Ito Y; Arakawa E; Kita Y; Terashita K; Niikura T; Nishimoto I
    J Neurochem; 2002 Feb; 80(3):426-37. PubMed ID: 11905990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells.
    Lessard CB; Lussier MP; Cayouette S; Bourque G; Boulay G
    Cell Signal; 2005 Apr; 17(4):437-45. PubMed ID: 15601622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.
    Marambaud P; Alves da Costa C; Ancolio K; Checler F
    Biochem Biophys Res Commun; 1998 Nov; 252(1):134-8. PubMed ID: 9813158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42.
    Tomita T; Tokuhiro S; Hashimoto T; Aiba K; Saido TC; Maruyama K; Iwatsubo T
    J Biol Chem; 1998 Aug; 273(33):21153-60. PubMed ID: 9694871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death and survival of neuronal cells exposed to Alzheimer's insults.
    Niikura T; Hashimoto Y; Tajima H; Nishimoto I
    J Neurosci Res; 2002 Nov; 70(3):380-91. PubMed ID: 12391601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of presenilin 2 inhibits protein synthesis.
    Gamliel A; Teicher C; Michaelson DM; Pradier L; Hartmann T; Beyreuther K; Stein R
    Mol Cell Neurosci; 2002 Jan; 19(1):111-24. PubMed ID: 11817902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
    J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.
    Tsukamoto E; Hashimoto Y; Kanekura K; Niikura T; Aiso S; Nishimoto I
    J Neurosci Res; 2003 Sep; 73(5):627-36. PubMed ID: 12929130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.
    Duering M; Grimm MO; Grimm HS; Schröder J; Hartmann T
    Neurobiol Aging; 2005 Jun; 26(6):785-8. PubMed ID: 15718035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
    Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
    J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease.
    Qin W; Peng Y; Ksiezak-Reding H; Ho L; Stetka B; Lovati E; Pasinetti GM
    Mol Psychiatry; 2006 Feb; 11(2):172-81. PubMed ID: 16331303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.